INTRODUCTION
Streptococcus pneumoniae is a major cause of morbidity and mortality in children and adults in Australia and worldwide (Hogg et al., 2000; Jette & Lamothe, 1989; Kertesz et al., 1998; Nielsen & Henrichsen, 1992) . Although penicillin resistance was first described in 1967 (Hansman & Bullen, 1967) , it did not become a significant problem in Australia until the 1990s (Turnidge et al., 1999) . Trials with a heptavalent conjugate vaccine have shown it to be highly effective in the prevention of invasive pneumococcal disease (IPD) (Black & Shinefield, 2002; Whitney et al., 2003) ; however, its efficacy for the prevention of middle ear infection is serotype-dependent (Eskola et al., 2001) . The aim of this study was to examine the serotypes and molecular clones of penicillin-nonsusceptible S. pneumoniae (PNSP) responsible for IPD and discharging ears in metropolitan New South Wales (NSW) to form a baseline prior to introduction of the heptavalent conjugate pneumococcal vaccine in Australia. This is the first indepth description of the molecular clones of pneumococci responsible for penicillin-nonsusceptibility in Australia.
METHODS
Study population and data collection. The NSW Pneumococcal Network comprises all public and private microbiology laboratories in metropolitan NSW, processing all the clinical microbiology specimens for the Greater Sydney region, which has a population of approximately 5 million people. Isolates from patients fulfilling the case definitions were referred for susceptibility testing and molecular typing to the NSW Pneumococcal Reference Laboratory. IPD was defined as isolation of S. pneumoniae from a normally sterile body site. Serotyping. Isolates were serotyped by the Quellung reaction using rabbit polyclonal antisera from the Statens Serum Institute, Copenhagen, Denmark.
Molecular typing of PNSP. Molecular typing was performed using multilocus sequence typing (MLST) as described previously . Forty-two PNSP isolates (28 from invasive disease and 14 from ears) chosen to maximize a diverse range of serotypes, patient locations, age categories and resistance profiles were subjected to MLST and their sequence types were determined by comparison with sequences at the MLST website (www.mlst.net). Novel sequences of alleles and sequence types were submitted to the MLST website for confirmation. Representative isolates of each sequence type were then typed by BOX PCR fingerprinting as described previously (van Belkum et al., 1996) using the primers: BoxA, 59-ATACTCTTCGA-AAATCTCTTCAAAC-39; BOXA1R, 59-CTACGGCAAGGCGACGC-TGACG-39. PCR products were run on a 2 % ethidium bromidecontaining agarose gel in TBE for 1.5 h at 80 V and banding patterns were compared. BOX PCR fingerprinting was used to screen other PNSP isolates for assigning sequence types. PNSP isolates with BOX PCR profiles that could not be assigned to the sequence types determined by MLST were sequenced. For some sequence types, PCR-RFLP of specific MLST alleles was also used in addition to BOX PCR fingerprinting. Sequence types ST236, ST320 and ST352 were differentiated by PCR-RFLP of the aroE allele with BsaHI, and AluI restriction digestion of the ddl and gki alleles. Sequence types that shared five of seven alleles were considered to belong to a clonal complex and were compared with global clones identified by the Pneumococcal Molecular Epidemiology Network (PMEN) (www. sph.emory.edu/PMEN/).
RESULTS AND DISCUSSION
Serotype and penicillin-nonsusceptibility in IPD During the study period there were 698 invasive isolates that were serotyped and had susceptibility results available. Of these, 97 (13.9 %) were penicillin-nonsusceptible. The serotypes of both penicillin-susceptible and -nonsusceptible isolates of S. pneumoniae responsible for IPD are displayed in Fig. 1 . Serotype 14 was the predominant serotype responsible for IPD, accounting for 35.1 % of all isolates. The next most common serotypes were 19F (13.1 %), 6B (12 %) and 18C (8.9 %). The heptavalent vaccine serotypes accounted for 613 (87.8 %) of all invasive isolates. Each serotype varied in its proportion of penicillin-nonsusceptibility, with serotypes 19F and 9V accounting for 30.9 and 26.8 %, respectively, of all the PNSP in IPD. The distribution of serotypes responsible for IPD in children in NSW is strikingly similar to the distribution of serotypes seen in the national Australian data for children less than 5 years (Watson et al., 2004) . Serotype 14 was the predominant serotype responsible for IPD in this study and in the national Australian data. Similarly, serotype 14 was the predominant serotype in IPD in Scotland (Clarke et al., 2004) and in children in Portugal (Serrano et al., 2005) .
Serotype and penicillin-nonsusceptibility in ear isolates
During the same time period, 607 discharging ear isolates were serotyped and had susceptibility results available. Of these, 157 (26.1 %) were penicillin-nonsusceptible. Among isolates from discharging ears (Fig. 2) , serotype 19F was the predominant serotype (207, 34.4 %). Other common serotypes were serotype 3 (10.6 %), 14 (9.3 %), 6B (8.1 %) and 23F (7.6 %). Overall, heptavalent vaccine serotypes account for 420 (69.8 %) isolates. Of note is the relatively high proportion of penicillin-nonsusceptibility (104/207, 50.2 %) of serotype 19F, accounting for 66.2 % of all PNSP from ears.
Molecular clones of PNSP
A total of 197 PNSP isolates were typed by MLST or BOX PCR fingerprinting and tested for susceptibilities to a range of antibiotics ( (157/197, 79 .6 %) from IPD and discharging ears. Other international PMEN clones found in this study were representatives of ST81, the Spain 23F -1 clone, ST90, the Spain 6B -2 clone, and ST9, the England 14 -9 clone.
The majority of serotypes and clones that were penicillinnonsusceptible are present within the heptavalent vaccine. Most of the PNSP of serotypes 14 and 9V were representatives of ST156, the Spain 9V -3 clone. This clone has been shown to comprise the majority of the isolates of serotype 9V in a study of invasive pneumococcal isolates in the USA (Gertz et al., 2003) and of serotypes 9V and 14 in a similar study in Portugal (Serrano et al., 2005) .
In our study, serotype 19F predominated from discharging ears. Of concern is the high rate of penicillin-nonsusceptibility in serotype 19F and the relatively poor efficacy that this serotype has demonstrated in a clinical trial of the heptavalent conjugate vaccine in preventing otitis media (Eskola et al., 2001) . Our data showed that the majority of penicillin-nonsusceptible serotype 19F isolates belonged to ST320, a novel sequence type that is related to the Taiwan 19F -14 clone. This clone is multi-resistant and has been isolated in Asia (Shi et al., 1998) , Africa (McGee et al., 2001) , the USA (Gertz et al., 2003) and Europe (www.mlst.net). Ongoing surveillance is essential to ensure that a reduction in ear disease due to this serotype will occur following the introduction of this vaccine into Australia. Notably, serotype 3 isolates accounted for 10 % of the ear isolates. This serotype is not covered by the heptavalent vaccine.
This study provides a characterization of the pneumococcal serotypes associated with IPD and discharging ears that will be useful for detecting potential selective effects of the vaccine. Recent reports have shown an increase in the isolation of serotype 19A from IPD in children in the USA in the post-vaccine period (Pai et al., 2005) . Thus surveillance should be continued, as it will be important to monitor the frequency and distribution of serotypes in the post-vaccine era. DSequence types first isolated in this study.
